| Stage | XOM | % of rev | IMO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $116B | 100.00% | $11.3B | 100.00% | XOM ×10.26 |
| Gross profit | $36.0B | 31.00% | $2.5B | 22.43% | XOM +8.6pp |
| Operating income | $19.7B | 16.94% | $2.0B | 17.91% | IMO +1.0pp |
| Pre-tax income | $19.4B | 16.74% | $2.0B | 17.81% | IMO +1.1pp |
| Net income | $14.9B | 12.83% | $1.5B | 13.63% | IMO +0.8pp |
| Stage | XOM | IMO | Gap · A − B |
|---|---|---|---|
| Revenue | $116B100.00% | $11.3B100.00% | XOM ×10.26 |
| Gross profit | 31.00%$36.0B | 22.43%$2.5B | XOM +8.6pp |
| Operating income | 16.94%$19.7B | 17.91%$2.0B | IMO +1.0pp |
| Pre-tax income | 16.74%$19.4B | 17.81%$2.0B | IMO +1.1pp |
| Net income |
| 12.83%$14.9B |
| 13.63%$1.5B |
| IMO +0.8pp |
No shared counterparties.